Chai hosts a L’Chaim at The Wallace Collection

Supporters and trustees given heartfelt thanks for their support at historic London house museum

Chai's CEO Lisa Steele and Chai's Chaiman Louise Hager with the Medical Advisory Panel. September 2024
Chai's CEO Lisa Steele and Chai's Chaiman Louise Hager with the Medical Advisory Panel. September 2024

The UK Jewish community’s leading cancer support organisation hosted a memorable L’Chaim at The Wallace Collection in central London this week.

Chai Cancer Care brought together more than 170 supporters, trustees, members of its Medical Advisory Panel and Advisory Board, to thank them in person for their loyal support.

Addressing guests, Chai’s Chairman, Louise Hager said: “What is not often recognised is the challenge of survivorship which just last week was brought to the fore through the very brave message beautifully articulated by the Princess of Wales in the video she shared with us all.

“The Princess epitomises the randomness of cancer. It doesn’t discriminate by age or social-economic standing. A young, fit, health-conscious person can still be affected. But this isn’t news to us at Chai. Over the past few years there has been a marked change in the demographic of our clients with 1 in 3 now being under 50. The impact of a single diagnosis, especially at such a young age, can often affect 4 generations within a single family and we have developed a range of services to meet their individual and specific needs.”

Guests at The Wallace Collection for Chai Cancer Care.

Professor Daniel Hochhauser, Professor of Medical Oncology at UCLH, Clinical Director of the Cancer Research UK-UCL Centre and member of Chai’s Medical Advisory Panel, updated guests on the direction of cancer care and the major innovation in personalised medicine.

He said, “Chai is so brilliant at taking forward the concept of tailoring individual treatment for cancer patients. It has really been a revolution, a paradigm shift that we can tailor cancer treatment to the individual cancer patient. Whilst there is this wonderful revolution going on, none of this reduces the need to have an organisation like Chai that can make sense to the patient. Every member of the Medical Advisory Panel are incredibly grateful to them.”

Charlotte Hildebrand, Chai’s Head of Client Services, Joe Hildebrand, Adrian Tookman, Chai Trustee and Chair of Chai’s Medical Advisory Panel

Chai’s also updated guests on the success of the NHS England Jewish BRCA genetic testing programme.

Since its launch in January, more than 23,000 tests have been distributed, marking a significant step forward in addressing genetic risks within the community. The initiative, in collaboration with Jnetics, aims to test 10% of the UK Jewish population within the next 18 months.

Chai’s chief executive, Lisa Steele, who announced her retirement after 12 years in post in July, said: “To so many Chai is a home, a refuge – it’s family. I feel incredibly proud and privileged to have played a part in Chai’s journey. A huge thank you must be given to all our trustees, advisory board members, medical panel, staff, counsellors, therapists and volunteers for everything that you do.

“Thank you also to our wonderful donors and supporters, without whom Chai would not be able to provide our specialised services and help those in the most trying of times.”

read more: